DIGITAL DROPLET PCR FOR MINIMAL RESIDUAL DISEASE MONITORING IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE PROSPECTIVE NORTHERN ITALY LEUKEMIA GROUP (NILG) ALL 10/07 STUDY

EHA Library, Francesco Ballardini, 4160411

DISCOVERY OF A NOVEL BCP-ALL MOLECULAR SUBGROUP DEFINED BY IGH::FENDRR GENE FUSION, FOXF1 OVEREXPRESSION AND KRAS A146 MUTATION

EHA Library, Sonja Bendig, 4160412

CREB-BINDING PROTEIN (CBP) DEFICIENCY IN THE EARLY B CELL COMPARTMENT IMPAIRS IMMUNE RESPONSES AND ALTERS GUT MICROBIOME DYNAMICS DURING CHRONIC VIRAL INFECTION

EHA Library, Zhe Lu, 4160414

DRUG-RESPONSE MODULATING GENES IN ETV6::RUNX1 CHILDHOOD LEUKEMIA

EHA Library, Laura Oksa, 4160415

SENSITISATION AND ERADICATION OF DRUG-RESISTANT PAEDIATRIC ETP-ALL BY REPURPOSING DECITABINE

EHA Library, Yizhou Huang, 4160422

CLUSTERING ANALYSIS OF ALTERNATIVE SPLICING IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED TARGETABLE SUBTYPE WITH GLOBAL SPLICING DEFECTS

EHA Library, Margaret Heung-Ling Ng, 4160424

ROLE OF TP53 MUTATIONS IN REFINING PROGNOSIS OF KTM2A-REARRANGED ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Mariangela Di Trani, 4160425

MOLECULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO A NOVEL AKR1C3-ACTIVATED PRODRUG IN PEDIATRIC LEUKEMIA

EHA Library, Faezeh Khalili, 4160436

WHOLE TRANSCRIPTOME SEQUENCING UNCOVERS KEY CODING AND NON-CODING BIOMARKERS IN IKZF1PLUS B-ALL

EHA Library, Gadha Krishna Leons, 4160438

IDENTIFYING SYNERGISTIC ACTIVITIES OF COMBINED INHIBITION OF TYROSINE KINASES AND ANTI-APOPTOTIC MOLECULES IN ABL1 FUSION-POSITIVE ALL

EHA Library, Johanna Bender, 4160439

ROLE OF FRUCTOSE TRANSPORTER (GLUT5) EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serene Xavier, 4160440

LONG-TERM OUTCOMES OF PEBL-ENGINEERED CD7 NANOBODY CAR-T (PA3-17 INJECTION) IN RELAPSED/REFRACTORY T-ALL/LBL: PHASE I TRIAL UPDATE

EHA Library, Meng Lv, 4160445

INOTUZUMAB OZOGAMICIN IN PEDIATRIC CD22-POSITIVE VERY HIGH RISK FIRST RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF THE ITCC-059 STUDY

EHA Library, Erica Brivio, 4160447

COMBINATION OF OLVEREMBATINIB AND VP REGIMEN AS FIRST-LINE THERAPY FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-ARM, MULTICENTRE, PHASE 2 TRIAL

EHA Library, Gaixiang Xu, 4160448

A RETROSPECTIVE STUDY OF RECIPIENT-DERIVED VERSUS DONOR-DERIVED CAR-T CELL THERAPY IN RELAPSED B-ALL PATIENTS AFTER TRANSPLANTATION

EHA Library, Lichao Liu, 4160451

PEGASPARGASE ADMINISTRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS AGED 55 YEARS OR OLDER TREATED WITH THE PEDIATRIC-INSPIRED PROGRAM LAL1913. A SUBANALYSIS OF THE CAMPUS ALL STUDY

EHA Library, Davide Lazzarotto, 4160452

MULTICENTER REAL-WORLD STUDY ON INOTUZUMAB AS A BRIDGE TO CELLULAR THERAPY IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alicia Aguirre, 4160453

CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY DISEASE

EHA Library, Zhao defeng, 4160454

T-ACUTE LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON DIFFERENCES IN IMMUNOPHENOTYPES AND GENE PROFILES BETWEEN CHILDREN AND ADULTS

EHA Library, Siyu Liu, 4160459

DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)

EHA Library, Mohamad Mohty, 4160460

GENETIC CHARACTERISTICS OF BCR::ABL1-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE INVOLVEMENT AND POST-HSCT SURVIVAL ANALYSIS

EHA Library, Tong Wang, 4160464

MRD-BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS BY THE RALL-2016M PROTOCOL: EFFECTIVE FOR BCP-ALL, SHOWS NO EFFICACY IN T-ALL

EHA Library, Olga Aleshina Gavrilina, 4160465

CLINICAL ANALYSIS OF SEQUENTIAL CAR-T CELL THERAPY COMBINED WITH VENETOCLAX, HYPOMETHYLATING AGENTS, AND PERSONALIZED TARGETED DRUGS IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Zhao defeng, 4160466

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY BODY MASS INDEX

EHA Library, Wendy Stock, 4160470

SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 4160484

PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.

EHA Library, Alicia Perzolli, 4160485

MICROBIOTA-INSPIRED COMPOUNDS AS NOVEL DRUG CANDIDATES TARGETING NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Miguel Ángel Navarro Aguadero, 4160486

DEEP IMMUNOPHENOTYPING BY MASS CYTOMETRY ELUCIDATES THE PROGENITOR TRAJECTORY OF ERYTHROID-DERIVED ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 4160487

OXPHOS-DRIVEN M2-POLARIZED MACROPHAGES SUPPORT LEUKEMIC CELL GROWTH THROUGH MITOCHONDRIAL TRANSFER

EHA Library, Wendy Boschloo, 4160491

DRUG PERSISTENCE TO RESISTANCE EVOLUTION ANALYSIS IN HUMAN LEUKEMIA REVEALS DIVERSE LEUKEMIA-INITIATING CELL PHENOTYPES

EHA Library, Michael Milyavsky, 4160496

DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS

EHA Library, Prasad Iyer, 4160497

IDENTIFICATION OF ELOVL6 AS A CAUSAL FACTOR AND POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Linhui Hu, 4160499

OVERCOMING AML HETEROGENEITY THROUGH MITOCHONDRIAL ACTIVITY AND AUTOPHAGY-INDUCED ENHANCEMENT OF AML CELLS BY BONE MARROW STROMAL CELLS

EHA Library, Shuqing Wang, 4160501

TARGETING DNA REPLICATION AND THE INTRA-S-PHASE CHECKPOINT FOR TREATMENT OF TP53-MUTATED AML

EHA Library, Sean Post, 4160502

DIRECT FUNCTIONAL HOXA9/DNA BINDING COMPETITORS VERSUS EPIGENETIC INHIBITORS OF HOXA9 EXPRESSION ON CELL PROLIFERATION, DEATH AND DIFFERENTIATION PROCESSES IN THE MODEL OF MLL-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Marie-Helene David-Cordonnier, 4160504

SINGLE-CELL IMMUNOMETABOLISM REVEALS A NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA AND UNCOVERS THE METABOLIC ROLE OF EXTRACELLULAR VESICLES

EHA Library, Dorian Forte, 4160511

DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT

EHA Library, Irene Zamanillo, 4160514

RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION

EHA Library, yan zhang, 4160523

STUDY ON THE SYNTHETIC LETHAL MECHANISM OF SELECTIVE KILLING OF ALDH2 DEFICIENT ACUTE MYELOID LEUKEMIA CELLS BY INHIBITING BRIP1

EHA Library, Jishi Wang, 4160524

FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION

EHA Library, Matteo Caridi, 4160527

ANTI-LEUKEMIC ACTIVITY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY AND IN COMBINATION WITH TARGETED AGENTS

EHA Library, Mi Ji Choi, 4160531

ABNORMAL DNA DAMAGE RESPONSE SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MONOCYTIC LEUKEMIA POST TRANSPLANTATION

EHA Library, Yukun FENG, 4160538

PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY

EHA Library, Martha L Arellano, 4160543

HYPOMETHYLANTS IN MONOTHERAPY OR COMBINED WITH VENETOCLAX: REAL-LIFE EXPERIENCE IN 1964 PATIENTS REPORTED TO THE PETHEMA-GPLA REGISTRY

EHA Library, Eliana Aguiar, 4160545

PROGNOSTIC VALUE OF MOLECULAR MEASURABLE RESIDUAL DISEASE MONITORED BY DIGITAL PCR BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TP53-MUTATED AML/MDS COHORT: A TROPHY STUDY

EHA Library, Yanmin Zhao, 4160548

UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) KMT2AR ACUTE LEUKEMIA

EHA Library, Ibrahim Aldoss, 4160549

VENETOCLAX PLUS HIGH-DOSE CYTARABINE AND MITOXANTRONE (HAM-VEN) IN RELAPSED/REFRACTORY AML: A REAL-WORLD ANALYSIS FROM SAL AND AMLCG STUDY CENTERS

EHA Library, Andrew Berdel, 4160552

UNVEILING DISTINCT MOLECULAR AND PROGNOSTIC FEATURES: AN RNA-BASED PROGNOSTIC MODEL FOR INFANT ACUTE MYELOID LEUKEMIA

EHA Library, YU TAO, 4160553

NUCLEOSIDE ANALOGUE-BASED INDUCTION (CLAG-M OR FLAGIDA) RESULTS IN HIGHER REMISSION RATES THAN STANDARD AML OR ALL-LIKE INTENSIVE INDUCTION REGIMENS IN MIXED PHENOTYPE ACUTE LEUKAEMIA. A STUDY FROM THE PETHEMA/PALG REGISTRIES.

EHA Library, Magdalena Karasek, 4160570

PROGNOSTIC SIGNIFICANCE OF RUNX1 MUTATIONS IN ACUTE MYELOID LEUKEMIA: IMPACT OF CONCURRENT GENETIC ALTERATIONS ON SURVIVAL

EHA Library, Hsin-Yu Lu, 4160575

COMPARABLE SURVIVAL OUTCOMES FOR SECONDARY AND DE NOVO ACUTE MYELOID LEUKEMIA AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Kehan Zhang, 4160579

PRELIMINARY RESULTS FROM RIVER-81, A PHASE 2 STUDY OF RVU120+VEN IN PATIENTS WITH AML FAILING FIRST LINE VEN+HMA

EHA Library, Noemi Angelosanto, 4160585

COMPARING OUTCOMES OF PATIENTS WITH DE NOVO AND SECONDARY AML, TREATED FRONTLINE WITH VENETOCLAX AND HYPOMETHYLATING AGENTS: A MULTICENTER RETROSPECTIVE STUDY.

EHA Library, Ilaria Tanasi, 4160589

A PHASE I STUDY OF VENETOCLAX, AZACITIDINE, AND MITOXANTRONE HYDROCHLORIDE LIPOSOME IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Wenxiang Ren, 4160591

OUTCOMES OF THE ACUTE MYELOID LEUKEMIA-DEFINING MECOM REARRANGEMENT DIFFER BASED ON BLAST COUNT AT DIAGNOSIS

EHA Library, Wei-Ying Jen, 4160592

ENHANCED PROGNOSIS OF DMCEBPABZIP-INF MUTATIONS IN ACUTE MYELOID LEUKEMIA: INSIGHTS FROM A MULTI-CENTER CHINESE COHORT

EHA Library, Guanghui Chang, 4160593

TREATMENT AND SURVIVAL OF MIXED PHENOTYPE ACUTE LEUKAEMIA - A POPULATION-BASED COHORT

EHA Library, Lisa-Maj Christensen, 4160597

TREATMENT INTENSITY IS ASSOCIATED WITH DISTINCT LONGITUDINAL TRAJECTORIES OF FRAILTY IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Victoria Ling, 4160598

THE EFFICACY AND PROGNOSTIC EVALUATION OF BTG1 IN HYPOMETHYLATING AGENTS TREATMENT FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Shuai Su, 4160599

TWICE WEEKLY LOW DOSE DECITABINE PLUS VENETOCLAX VERSUS AZACYTIDINE PLUS VENETOCLAX IN THE FRONTLINE TREATMENT OF ACUTE MYELOID LEUKEMIA, INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Ciprian Tomuleasa, 4160601

CD4+ T CELLS, GRANZYME B+ NK, MZ B CELLS AND DIFFERENTIATED/SENESCENT CD4+CD28- T CELLS AFTER INDUCTION TREATMENT PREDICT AML PATIENT'S OUTCOME

EHA Library, Xin Huang, 4160602

FEASIBILITY AND SAFETY OF OUTPATIENT CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Laura Curras Sanchez, 4160606

EFFICACY AND SAFETY OF VAC (VENETOCLAX, AZACITIDINE, CHIDAMIDE) REINDUCTION TREATMENT FOR UNFIT ACUTE MYELOID LEUKEMIA PATIENTS FAILED TO RESPOND TO ONE CYCLE OF VA INDUCTION

EHA Library, Shengli Xue, 4160607

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH AML FROM 65 TO 74 YEARS UNFIT FOR FIRST-LINE INTENSIVE CHEMOTHERAPY IN JAPAN.

EHA Library, Fumiaki Fujii, 4160612

THE FUS::ERG FUSION IN ACUTE MYELOID LEUKEMIA: INSIGHTS INTO MOLECULAR PROFILES AND PROGNOSTIC IMPLICATIONS

EHA Library, Bingbing Han, 4160613

REAL-LIFE STUDY ON GILTERITINIB RELATED INFECTIONS (GILTERINF): AN ITALIAN SEIFEM STUDY

EHA Library, Elisa Buzzatti, 4160619

OUTCOMES OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ACUTE MYELOID LEUKEMIA: THE THREE-SITE MAYO CLINIC CANCER CENTER EXPERIENCE.

EHA Library, Jabra Zarka, 4160620

THE PREDICTIVE ROLE OF HEMATOLOGIC RECOVERY IN THE PROGNOSIS OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH AZACITIDINE-VENETOCLAX

EHA Library, Yan Li, 4160624

THE LANDSCAPE OF CLONAL HEMATOPOIESIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Othman Al-Sawaf, 4160629

EGR2 MUTATIONS COOPERATE IN ACTIVATING NOTCH-1 PATHWAY AND LEAD TO BTK INHIBITORS RESISTANCE IN CLL

EHA Library, Alessia Morabito, 4160630

DIAGNOSTIC CRITERIA FOR NK-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA: VALIDATION THROUGH A MULTICENTRIC INTERNATIONAL STUDY

EHA Library, Thierry Lamy, 4160631

A CLINICAL-MOLECULAR MODEL FOR A PERSONALISED PREDICTION OF TIME TO FIRST TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Aleix Real, 4160632

VENETOCLAX-ACALABRUTINIB FOR CLL PATIENTS RELAPSING AFTER VENETOCLAX-ANTICD20 TREATMENT: HIGHLY EFFECTIVE AND LOW TOXICITY. INTERIM ANALYSIS OF HOVON 159/REVEAL PHASE 2 TRIAL

EHA Library, Sabina Kersting, 4160638

10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE-2 STUDY OF IBRUTINIB OR IBRUTINIB PLUS RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Jan Burger, 4160645

IMPACT OF IBRUTINIB ON QUALITY OF LIFE IN PATIENTS WITH EARLY-STAGE, ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM THE PHASE III CLL12 TRIAL - MATCHING SAFETY TO PATIENT-REPORTED OUTCOMES

EHA Library, Ellinor Goergen, 4160651

FIRST WORLDWIDE REAL-LIFE DATA ON FIXED-DURATION IBRUTINIB+VENETOCLAX TREATMENT FOR PREVIOUSLY UNTREATED CLL/SLL PATIENTS: INITIAL INTERIM ANALYSIS OF SPAIN´S LI+VE OBSERVATIONAL STUDY

EHA Library, JOSE ANGEL HERNANDEZ RIVAS, 4160654

GERMLINE VARIANTS IN PEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Tabita Ghete, 4160660

ASSESSMENT OF TRANSITIONING FROM HIGH-POTENCY TO LOW-POTENCY INHIBITORS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DOWNGRADING-IMPACT (D-IMPACT) PROJECT, A CML CAMPUS STUDY

EHA Library, Simona Bernardi, 4160665

ASC4OPT STUDY: HIGH EFFICACY AND FAVORABLE TOLERABILITY OF ASCIMINIB ONCE OR TWICE DAILY IN CML PATIENTS WITH SUBOPTIMAL RESPONSE, RESISTANCE OR INTOLERANCE OF 2 OR MORE TYROSINE KINASE INHIBITORS

EHA Library, Andreas Hochhaus, 4160668

UPDATED RESULTS OF MANAGED-ACCESS PROGRAM (MAP) OF ASCIMINIB USE IN CHRONIC MYELOID LEUKEMIA PATIENTS IN 3 CLINICAL CENTERS.

EHA Library, Ekaterina Chelysheva, 4160669

IMPACT OF ADVERSE EVENTS ON QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA (CML) - RESULTS FROM THE PATIENT SURVEY ON HUMANISTIC BURDEN OF INTOLERANCE TO FIRST OR SECOND TKIS (SHIFT) STUDY IN THE US

EHA Library, David Wei, 4160670

IMPACT OF PONATINIB TREATMENT ON PREGNANCY OUTCOMES

EHA Library, Elisabetta Abruzzese, 4160673

ANALYSIS OF FACTORS INFLUENCING TREATMENT-FREE REMISSION OUTCOMES AFTER IMATINIB DISCONTINUATION IN PAEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Yanli Zhang, 4160674

TRANSCRIPTIONAL REMODELING OF THE NON-IMMUNE BONE MARROW MICROENVIRONMENT IN MDS PATIENTS WITH SF3B1 MUTATIONS: INSIGHTS INTO BIOLOGY AND THERAPEUTIC IMPLICATIONS

EHA Library, Isabel A. Calvo, 4160684

CCR2-DIRECTED TARGETING OF MONOCYTIC-BIASED PROGENITOR AND MONOCYTIC POPULATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MONOCYTIC LEUKEMIA

EHA Library, Guillermo Montalban-Bravo, 4160686

PATHOPHYSIOLOGICAL ABNORMALITIES OF RED BLOOD CELLS IN MYELODYSPLASTIC SYNDROMES AS POTENTIAL DIAGNOSTIC AND THERAPEUTIC MARKERS

EHA Library, Pinelopi Vryttia, 4160689

LUSPATERCEPT MODULATES THE TRANSCRIPTIONAL PROGRAM OF HSPCS OF MDS PATIENTS AT THE SINGLE CELL LEVEL.

EHA Library, Ioannis Kotsianidis, 4160690

MEASURABLE RESIDUAL DISEASE IN CD34+ CELLS IN MYELODYSPLASTIC SYNDROME AFTER ALLOGENIC STEM CELL TRANSPLANTATION

EHA Library, Carolin Lindholm, 4160699

ALLOGENEIC TRANSPLANTATION OUTCOMES OF MDS/AML: RISK VERIFICATION AND MATCHED ANALYSIS WITH AML—A MULTICENTER STUDY

EHA Library, Yuhua Ru, 4160702

A PHASE I OPEN LABEL STUDY OF FOSTAMATINIB, A SYK INHIBITOR, IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Jennifer Croden, 4160712

VALIDATION OF MASP-3 AS A NOVEL PROXIMAL TARGET FOR COMPLEMENT-MEDIATED DISEASES: LEARNINGS FROM NONCLINICAL AND CLINICAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) STUDIES

EHA Library, W. Jason Cummings, 4160716

THE ROLE OF CD8+CD28-REGULATORY T CELLS IN ACQUIRED APLASTIC ANEMIA

EHA Library, Meili Ge, 4160722

ANALYSIS OF THE RECOVERY OF IMMUNE STATUS IN THE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AFTER TREATMENT WITH COMPLEMENT C5 INHIBITOR

EHA Library, Rong Fu, 4160725

HETROMBOPAG COMBINED WITH CYCLOSPORINE A AS FIRST-LINE TREATMENT IN PATIENTS WITH NON-SEVERE APLASTIC ANEMIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY

EHA Library, Xin Zhao, 4160726

EVALUATING THE SAFETY AND EFFICACY OF MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH CHRONIC NEUTROPENIC DISORDERS: RESULTS FROM THE PHASE 2 STUDY

EHA Library, Julia Warren, 4160729

A BENEFIT ASSESSMENT OF PEGCETACOPLAN DOSE INCREASE IN THE PHASE 3 PEGASUS TRIAL OF PNH PATIENTS WITH DIFFICULT-TO-CONTROL DISEASE

EHA Library, Morag Griffin, 4160737

BENEFIT OF PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IRRESPECTIVE OF BASELINE TRANSFUSION STATUS

EHA Library, Britta Höchsmann, 4160740

MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, ALLOWS FOR GRANULOCYTE-COLONY STIMULATING FACTOR DOSE DE-ESCALATION IN PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA AND CONGENITAL NEUTROPENIA

EHA Library, Julia Warren, 4160744

ANELLOVIRUS-ASSOCIATED SUBOPTIMAL HEMATOLOGICAL RECOVERY IN SEVERE APLASTIC ANEMIA AFTER IMMUNOSUPPRESSIVE THERAPY

EHA Library, Guangsheng He, 4160745

ZMYND8 READS H3K36ME2 TO ACTIVATE CEBPE TRANSCRIPTION AND SUPPRESS MULTIPLE MYELOMA PROGRESSION THROUGH THE INHIBITION OF ADAPTIVE UPR PATHWAYS

EHA Library, Bing Chen, 4160751